Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CarobWay is an Israeli FoodTech and AgTech company dedicated to unlocking the full nutritional and functional potential of the carob tree (Ceratonia siliqua). The company has developed a vertically integrated model that spans from sustainable cultivation and advanced genomic selection of carob varieties to the industrial production of high-value ingredients. Their product portfolio includes low-glycemic index sweeteners, fibers, and proteins designed for use in the food, supplement, and potentially pharmaceutical industries. By utilizing a data-driven approach to optimize the carob's bioactive compounds, CarobWay aims to provide healthy, sustainable alternatives to sugar and synthetic additives while promoting metabolic health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CarobFoods.